Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,357 GBX | +2.18% | +1.50% | +14.51% |
May. 23 | Indivior Confirms FY24 Outlook | MT |
May. 23 | Transcript : Indivior PLC - Shareholder/Analyst Call |
Business Summary
Number of employees: 1,000
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Buprenorphine-based Prescription Drugs
100.0
%
| 731 | 100.0 % | 879 | 100.0 % | +20.21% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
83.4
%
| 593 | 81.1 % | 734 | 83.4 % | +23.63% |
Rest of World
16.1
%
| 133 | 18.2 % | 142 | 16.1 % | +6.34% |
United Kingdom
0.5
%
| 5 | 0.7 % | 4 | 0.5 % | -17.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Crossley
CEO | Chief Executive Officer | - | 11-12-31 |
Ryan Preblick
DFI | Director of Finance/CFO | - | 11-12-31 |
Cynthia Cetani
CMP | Compliance Officer | - | 18-09-30 |
Chief Tech/Sci/R&D Officer | - | 14-11-30 | |
Kathryn Hudson
IRO | Public Communications Contact | 50 | 15-07-14 |
Jason Thompson
IRC | Investor Relations Contact | - | - |
Vishal Kalia
PRN | Corporate Officer/Principal | - | - |
Hillel West
PRN | Corporate Officer/Principal | - | - |
Jon Fogle
HRO | Human Resources Officer | - | 14-09-30 |
Richard Simkin
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 19-10-31 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 22-05-31 |
Mark Stejbach
BRD | Director/Board Member | 61 | 21-03-23 |
Jerome Lande
BRD | Director/Board Member | 48 | 21-03-23 |
Peter Bains
BRD | Director/Board Member | 65 | 19-07-31 |
Mark Crossley
CEO | Chief Executive Officer | - | 11-12-31 |
Juliet Thompson
BRD | Director/Board Member | 57 | 21-03-23 |
Director/Board Member | 60 | 21-03-23 | |
Ryan Preblick
DFI | Director of Finance/CFO | - | 11-12-31 |
Keith Humphreys
BRD | Director/Board Member | - | Nov. 08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 134,887,108 | 130,460,459 ( 96.72 %) | 0 | 96.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
AELIS FARMA 5.29% | 701,469 | 5.29% | 9,750,594 $ |
Company contact information
Indivior PLC
10710 Midlothian Turnpike Suite 125
23235, North Chesterfield
+804 379 1090
http://indivior.comGroup companies
Name | Category and Sector |
---|---|
RBP Global Holdings Ltd.
RBP Global Holdings Ltd. Financial ConglomeratesFinance Part of Indivior PLC, RBP Global Holdings Ltd. is a British investment company. The company is based in Slough, UK. RBP Global Holdings was founded in 2013. |
Financial Conglomerates
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.30% | 2.28B | |
+8.35% | 8.79B | |
-15.14% | 4.88B | |
+50.73% | 4.73B | |
+4.36% | 3.92B | |
-26.13% | 2.2B | |
+16.45% | 2.11B | |
-33.59% | 2.08B | |
-0.50% | 1.64B | |
-4.04% | 1.53B |
- Stock Market
- Equities
- INDV Stock
- Company Indivior PLC